A Review of the mRNA-Based Drug Development Landscape

• An overview of the preclinical and clinical landscape
• A review of recent developments within the commercial landscape
• Insights into the future of mRNA therapies including therapies to watch

Speakers:

Victoria Marshall

RNA Lead Research Analyst, Beacon Research Operations

Hanson Wade